ISIN
CH0027148649
Ticker
SANN
Sector
Sub-Industry
Country
Switzerland
Year Founded
2004
We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF).
We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.
91
Worldwide
Date | Trading entity / Person | Association | Trade type | Volume |
---|---|---|---|---|
11.01.2022 | None | Non-Executive member | Buy | CHF 42,600.00 |
10.01.2022 | None | Executive member | Buy | CHF 14,420.00 |
05.01.2022 | None | Executive member | Buy | CHF 37,000.00 |
CH0027148649
54930035HAOFTTQH0U85
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.